83
Participants
Start Date
May 30, 2022
Primary Completion Date
March 3, 2026
Study Completion Date
May 30, 2026
SHR-A1904
Single Arm :It is a dose-escalation and dose-expansion study of SHR-A1904 in subjects with advanced solid tumors
RECRUITING
Scientia Clinical Research Ltd, Randwick
COMPLETED
Genesis Care North Shore, St Leonards
RECRUITING
Macquarie University, Sydney
RECRUITING
Westmead Hospital, Westmead
COMPLETED
Central Coast Local Health District, Gosford
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Peninsula and South Eastern Haematology & Oncology Group (PASO), Frankston
NOT_YET_RECRUITING
Gold Coast Private Hospital, Southport
RECRUITING
One Clinical Research (OCR), Nedlands
RECRUITING
CHA Bundang Medical Centre, Seongnam-si
RECRUITING
Ajou University Hospital, Gyeonggi-do
RECRUITING
Chungbuk National University Hospital, Cheongju-si
ACTIVE_NOT_RECRUITING
Prisma Health, Greenville
RECRUITING
Mount Sinai Comprehensive Cancer Center, Miami Beach
RECRUITING
Comprehensive Hematology Oncology, St. Petersburg
TERMINATED
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Dong-A University Hospital, Busan
RECRUITING
LSU Health Sciences Center, New Orleans
NOT_YET_RECRUITING
LSU-LCMC Cancer Center Louisiana State University (LSU) Health Sciences Center, New Orleans
ACTIVE_NOT_RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
ACTIVE_NOT_RECRUITING
Rhode Island Hospital, Providence
RECRUITING
Sydney South West Private Hospital, Liverpool
RECRUITING
National Institute of Oncology, Arensia Research Clinic, Chisinau
RECRUITING
Seoul National University Bundang Hospital, Seongnam
RECRUITING
Korea University Anam Hospital, Seoul
RECRUITING
Korea University Guro Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
Jiangsu HengRui Medicine Co., Ltd.
INDUSTRY